Bisagni, G; Musolino, A.; Panebianco, M.; De Matteis, A.; Nuzzo, F.; Ardizzoni, A.; Gori, S.; Gamucci, T.; Passalacqua, R.; Gnoni, R.; Moretti, G.; Boni, C., The Breast Avastin Trial: Phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer, «CANCER CHEMOTHERAPY AND PHARMACOLOGY», 2013, 71, pp. 1051 - 1057 [articolo]
Musolino, Antonino; Michiara, Maria; Conti, Giovanni Maria; Boggiani, Daniela; Zatelli, Marella; Palleschi, Dario; Bella, Maria Angela; Sgargi, Paolo; Di Blasio, Beatrice; Ardizzoni, Andrea, Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study, «JOURNAL OF CLINICAL ONCOLOGY», 2012, 30, pp. 2362 - 2368 [articolo]
Guarneri, V.; Frassoldati, A.; Bottini, A.; Cagossi, K.; Bisagni, G.; Sarti, S.; Ravaioli, A.; Cavanna, L.; Giardina, G.; Musolino, A.; Untch, M.; Orlando, L.; Artioli, F.; Boni, C.; Generali, D. G.; Serra, P.; Bagnalasta, M.; Marini, L.; Piacentini, F.; D'Amico, R.; Conte, P., Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase II CHER-LOB study, «JOURNAL OF CLINICAL ONCOLOGY», 2012, 30, pp. 1989 - 1995 [articolo]
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A, Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma, «CANCER», 2011, 117, pp. 964 - 973 [replica/breve intervento]
Musolino A; Ciccolallo L; Panebianco M; Fontana E; Zanoni D; Bozzetti C; Michiara M; Silini EM; Ardizzoni A, Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study, «CANCER», 2011, 117, pp. 1837 - 1846 [replica/breve intervento]
Boggiani D; Musolino A; Panebianco M; Franciosi V; Vasini G; Salvagni S; Ardizzoni A, ACTIVITY AND SAFETY OF DOSE-ADJUSTED INFUSIONAL CHOP CHEMOTHERAPY WITH RITUXIMAB (DA-POCH-R) IN VERY ELDERLY PATIENTS WITH POOR-PROGNOSTIC UNTREATED DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA, «ANNALS OF ONCOLOGY», 2010, 21, pp. 352 - 352 [abstract]
Musolino, A; Guazzi, A; Nizzoli, R; Panebianco, M; Mancini, C; Ardizzoni, A, Accuracy and relative value of bone marrow aspiration in the detection of lymphoid infiltration in non-Hodgkin lymphoma, «TUMORI», 2010, 96, pp. 24 - 27 [articolo]
Musolino A; Michiara M; Conti GM; Boggiani D; Bozzani F; Zatelli M; Sgargi P; Ardizzoni A, HER2 STATUS AS PREDICTOR OF MAMMOGRAPHIC SCREENING DETECTION: COMPARISON OF INTERVAL- AND SCREEN-DETECTED BREAST CANCERS, «ANNALS OF ONCOLOGY», 2010, 21, pp. 78 - 79 [replica/breve intervento]
A. Musolino; M. Panebianco; E. Zendri; M Santini; S. Di Nuzzo; Ardizzoni A, Hypertriglyceridaemia with bexarotene in cutaneos T cell Lymphoma: the role of Omega-3 fatty acids, «BRITISH JOURNAL OF HAEMATOLOGY», 2009, 145, pp. 84 - 86 [replica/breve intervento]
Musolino A; Naldi N; Bortesi B; Pezzuolo D; Capelletti M; Missale G; Laccabue D; Zerbini A; Camisa R; Bisagni G; Neri TM; Ardizzoni A, Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer, «JOURNAL OF CLINICAL ONCOLOGY», 2008, 26, pp. 1789 - 1796 [replica/breve intervento]
Musolino A; Bella MA; Bortesi B; Michiara M; Naldi N; Zanelli P; Capelletti M; Pezzuolo D; Camisa R; Savi M; Neri TM; Ardizzoni A, BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study, «THE BREAST», 2007, 16, pp. 280 - 292 [replica/breve intervento]
Musolino A; Naldi N; Bortesi B; Capelletti M; Pezzuolo D; Michiara M; Missale G; Laccabue D; Zerbini A; Camisa R; Ardizzoni A, Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/neu-positive metastatic breast cancer, «BREAST CANCER RESEARCH AND TREATMENT», 2007, 103, pp. 119 - 120 [abstract]
Negri F; Musolino A; Naldi N; Bortesi B; Boni C; Bisagni G; Camisa R; Ardizzoni A, Immunoglobulin g fragment c receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with Cetuximab-based therapy, «ANNALS OF ONCOLOGY», 2007, 18, pp. 10 - 10 [abstract]
Musolino A; Guazzi A; Lazzaretti M; Pezzuolo D; Calzetti C; Degli Antoni A; Ardizzoni A, Intracranial hematopoiesis in a patient with AIDS-related central nervous system lymphoma and severe pancytopenia., «HAEMATOLOGIA», 2007, 92, pp. 59 - 61 [replica/breve intervento]
BOZZETTI C; NIZZOLI R; MUSOLINO A; MARTELLA EM; CRAFA P; LAGRASTA CA; CAMISA R; BONATI A; LUNGHI P; ARDIZZONI A, P73 and p53 pathway in human breast cancer, «JOURNAL OF CLINICAL ONCOLOGY», 2007, 25, pp. 1451 - 1453 [replica/breve intervento]
